Abortion Drug Offers Hope for People with Central Serous Chorioretinopathy

(Updated August 18, 2018) An abortion drug known as ru486 is showing potential as a treatment for central serous chorioretinopathy (CSC), a condition which can lead to loss of central vision. The drug, also called mifepristone, blocks the action of progesterone, a hormone necessary to sustain pregnancy. It is also a potent antiglucocorticoid agent. Glucocorticoids [Read More]

Biocurrent Therapy: A Promising Treatment for Dry AMD

by Dan Roberts with additional material by Wendy Strouse Watt, O.D. Originally Published October 26, 2005 Acuity Medical has successfully completed a proof of concept, double-masked trial of its TheraMac™ device for the treatment of dry age-related macular degeneration (AMD). The therapy developed from early studies of microcurrent stimulation, with improvements in the science and [Read More]

Photodynamic Therapy

by Dan Roberts Originally posted on MDSupport and updated in September 2005: QLT’s preliminary results found that Visudyne in an occult trial did not achieve its primary endpoint after two years. ———————————– Photodynamic therapy has been shown to be effective in helping to prevent further loss of sight in people who are afflicted by the [Read More]

Microcurrent Stimulation Testimonial "Blown Out Of Proportion"

According to son, Sam Snead’s vision did not benefit from the controversial therapy by Dan Roberts Originally published, January 20, 2003 Microcurrent stimulation (MCS) therapy “didn’t work for my father,” said Sam Snead, Jr., son of the late champion golfer. Sam Snead, Sr., who passed away last year at the age of 89, underwent MCS [Read More]